US FDA accredits GS1, HIBCC for issuing device identifiers as UDI rule architect departs
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has accredited two global standards organizations, GS1 and the Health Industry Business Communications Council (HIBCC), for issuing unique device identifiers to support the implementation of the agency's new UDI regulations1,2. Separately, Jay Crowley, who was instrumental in authoring the FDA's UDI rule, is leaving the agency to join private consultancy firm USDM Life Sciences3.